Quality of Life Associated with Cochlear Implantation
Measures of health-related quality of life (QOL) provide unique information about the impact of a disability and its treatment. The NIH, FDA and CMS have all added QOL as outcome measures for healthcare interventions. Conventional measures of CI outcomes such as auditory and communicative competence (i.e., word and sentence recognition) are essential but do not adequately capture the broad impact of deafness on a patient’s physical, behavioral, social and emotional functioning. A poor correlation between self-report and such typically measured outcomes represents a significant gap in how we assess CIs in adults, which impairs clinicians’ ability to comprehensively quantify CI benefits, preoperatively counsel patients on CI expectations, and provide intervention in areas not related to communication. The session will examine the use of QOL instruments to allow direct input from the CI population and families regarding CI benefits on an individual’s daily functioning, beyond speech understanding.
CI Candidacy in 2018
When cochlear implants were first introduced, candidacy determination was a straightforward process: patients were expected to have bilateral profound deafness and demonstrate no benefit from hearing aids, which often meant 0% speech recognition. As technology has improved, CI candidacy has expanded to include patients with greater amounts of residual hearing and greater speech recognition skills. This session will review recent changes in CI Candidacy, including the use of contemporary measures to evaluate traditional candidates, medical/surgical considerations when determining CI Candidacy, the role that age and cognition play in candidacy considerations, and expansion of candidacy to include patients with SSD and asymmetric hearing losses.
Parental Engagement in Pediatric CI Outcomes
Parents and the home routines they create play central roles in a child’s development. Research in pediatric CI outcomes has identified specific ways in which significant caregivers can promote acquisition and growth in spoken language and literacy skills in children with hearing loss. This research also highlights the effectiveness of providing parents and caregivers with specific knowledge and strategies that can be woven into family life to support their child’s communication and literacy development.
Cochlear Implant Practice Management: Maximizing Value for Optimal Delivery of Care
As indications for cochlear implantation continue to expand, constraints in serving patients at already busy cochlear implant centers will worsen. Some centers have instituted innovative practices to optimize efficiency in delivering clinical services. This session will examine techniques and technologies already in place as well as possible future innovations that could improve efficiency and value for CI centers and patients. Such innovations include telehealth in the evaluation, pre-operative, and post-operative elements of CI; in-center programming efficiencies; outsourced audiology services; and industry utilization. Patients may benefit from satellite centers in smaller cities or rural areas that are now poorly served. Existing and needed research to guide adoption and use of such innovative practices will be reviewed.
Congressman David B. McKinley Opened CI2018 DC
Congressman McKinley is Co-Chair of the Congressional Hearing Health Caucus. He is the only Member of Congress with a cochlear implant and is an active and effective advocate for hearing healthcare Issues. Congressman McKinley will open the conference on Thursday, March 8th.
Dr. John Niparko Memorial Lecture
This year’s John Niparko Lecture was given by William G. Kronenberger PhD. The topic of his lecture was “Executive Functioning and Language Development in Children with Cochlear Implants.” Reduced access to early auditory and spoken language experiences can influence the development of executive functioning (EF; active self-regulatory processes to manage and direct thinking and behavior) in deaf children with cochlear implants (CIs). Because EF is used extensively by children with CIs during speech-language processing, EF variability is linked to speech-language outcomes. Interventions to improve EF offer the potential to enhance neurocognitive and speech-language outcomes following cochlear implantation.
Dr. Kronenberger is Professor and Director of the Section of Psychology and Executive Vice Chair of the Department of Psychiatry at Indiana University School of Medicine. He serves as Chief of the Pediatric Psychology Testing Clinic and Co-Chief of the ADHD Clinic at Riley Hospital for Children. Dr. Kronenberger has been an investigator on multiple projects addressing neurocognitive, psychosocial, and spoken language development in children with hearing loss and cochlear implants or hearing aids. He is the author of several tests on these topics.
To view Dr. Kronenberger's powerpoint handouts click HERE.
After the premiere, a panel discussion with five of the young adults in the film and Jane Madell PhD, filmmaker and their childhood audiologist, was held immediately after the premiere. The panelists discuss their experiences navigating their way through school, friendships and slumber parties. They share stories about family support and judgment by others, career challenges and successes, and the importance of accepting their deafness on their own terms.
CI2018 Scholarship Award
The Scholarship Committee of the American Cochlear Implant Alliance selected twenty-one outstanding individuals to receive scholarships to attend CI2018 DC Emerging Issue in Cochlear Implantation. Click HERE to view the recipients of this year's scholarship award and to learn more about upcoming scholarship opportunities.
Meet our Exhibitors
The ACI Alliance would like to thank all the exhibitors for their support of the CI2018 DC Meeting.